Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2008 October;60(5) > Minerva Ginecologica 2008 October;60(5):389-98

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEWS  


Minerva Ginecologica 2008 October;60(5):389-98

Copyright © 2008 EDIZIONI MINERVA MEDICA

language: English

HELLP syndrome and placental inflammatory pathology

Landi B., Tranquilli A. L.

Maternal and Children Science Institute, Marche University, Ancona, Italy


PDF  


HELLP syndrome, acronym for hemolysis (H), elevated liver enzymes (EL), and low platelet count (LP), is a multisystemic disease that complicates pregnancy and is considered a severe variant of hypertensive disorders in pregnancy, that causes maternal and perinatal mortality and morbidity. The pathogenesis of HELLP syndrome is not completely understood and the obstetric approach with the induction of delivery is still the only specific therapy in HELLP syndrome. It is well known that the placenta and the incomplete trophoblast invasion of spiral arteries have a central role, but especially in severe pre-eclampsia and in the HELLP syndrome there is a systemic endothelial activation and damage. In this review we emphasize the inflammatory hypothesis and the role of inflammatory cytokines deriving from placenta in pre-eclampsia and HELLP syndrome, also in the light of our recent studies on cytokines pattern.

top of page

Publication History

Cite this article as

Corresponding author e-mail